anti-Respiratory Syncytial Virus (RSV) Fusion Protein antibody product blog
Tags: Antibody; Monoclonal Antibody; Respiratory Syncytial Virus (RSV) Fusion Protein; anti-Respiratory Syncytial Virus (RSV) Fusion Protein antibody;
The Respiratory Syncytial Virus (RSV) Fusion Protein n/a (Catalog #MBS310161) is an Antibody produced from Host: MouseSource: Ascites and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Respiratory Syncytial Virus (RSV) Fusion Protein can be used in a range of immunoassay formats including, but not limited to, EIA/ELISA, Immunofluorescence Assay, Neut, Immunoassay Antibody Pairs. Researchers should empirically determine the suitability of the Respiratory Syncytial Virus (RSV) Fusion Protein n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: RSV viral lysate (Long strain)
Affinity Constant: Not determined. Buffer: 0.01M PBS, pH 7.2
This product contains no stabilizing proteins.
Preservative: 0.1% Sodium azide
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Respiratory Syncytial Virus (RSV) Fusion Protein are readily searchable from our website. Different antibodies against the same target such as Respiratory Syncytial Virus (RSV) Fusion Protein may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.